GGrantIndex
Sort

15,273 grants matching antimicrobial resistance

Antimicrobial Resistance in Bacteria

$555,892
Stanley N Cohen · Stanford University · R01 · FY2008 · AI

Modification of Bone Grafts for Orthopaedic Procedures

$555,859
Francis Young-In Lee · Yale University · R01 · FY2018 · AR

Inhibition of MEP pathway Isoprenoid Biosynthesis

$555,821
Cynthia Schieck Dowd · George Washington University · R01 · FY2016 · AI

Determining the contribution of zinc deficiency to perinatal Group B Streptococcus infections

$555,769
Jennifer A Gaddy · Vanderbilt University Medical Center · R01 · FY2019 · HD

Oxidative Stress Responses in Oral Streptococci

$555,662
Robert G Quivey · University Of Rochester · R01 · FY2019 · DE

Role of Notch-1/PLA2-IIA in oral dysbiosis, inflammation, and periodontal disease

$555,461
Octavio Alberto Gonzalez · University Of Kentucky · R01 · FY2021 · DE

The protease network that regulates innate immunity in mosquitoes

$555,337
Kristin Michel · Kansas State University · R01 · FY2019 · AI

Discovery and validation of broadly effective LpxH inhibitors as novel therapeutics against multi-drug resistant Gram-negative pathogens

$555,313
Pei Zhou · Duke University · R01 · FY2020 · AI

A Novel Drug for Septicemia Targets A1 ARs

$555,195
Constance Neely Wilson · Endacea, Inc. · R42 · FY2009 · AI

Improving perinatal outcomes among Kenyan pregnant women affected by HIV with an integrated STI testing model

$555,083
Jillian Pintye · University Of Washington · R01 · FY2025 · HD

Epidemiology and Etiology of Hospitalized Pneumonia in Children

$555,082
Krow Ampofo · University Of Utah · U18 · FY2010 · IP

Ag-specific gamma delta T cells and immunity to TB/AIDS-related TB

$555,046
Zheng W Chen · University Of Illinois At Chicago · R01 · FY2015 · OD

TH17 cells in AIDS pathogenesis and HIV vaccines

$554,946
Mirko Paiardini · Emory University · R01 · FY2012 · AI

Dispersion and the Biofilm Matrix of Pseudomonas aeruginosa

$554,667
Karin Sauer · State University Of Ny,Binghamton · R01 · FY2022 · AI

Development and evaluation of a second-generation fungerp for systemic and cutaneous C. auris infection

$554,444
Mahmoud A Ghannoum · Case Western Reserve University · R01 · FY2023 · AI

Discovering Antimicrobial Drugs from Symbiotic Actinobacteria from Terrestrial

$553,948
Cameron Robert Currie · University Of Wisconsin-Madison · U19 · FY2016 · AI

Lactoferrin and lysozyme to promote nutritional, clinical, and enteric recovery: A factorial placebo-controlled randomized trial among children with diarrhea and malnutrition

$553,912
Patricia Pavlinac · University Of Washington · R01 · FY2022 · HD

Antimicrobial Resistance in Bacteria

$553,823
Stanley N Cohen · Stanford University · R01 · FY2009 · AI

Quinolone resistant E coli in long term care facilities

$553,684
Ebbing Lautenbach · University Of Pennsylvania · R01 · FY2007 · AG

Insulin Signaling Activates Urothelial Defenses to Reduce Urinary Tract Infection Susceptibility

$553,600
John David Spencer · Research Inst Nationwide Children'S Hosp · R01 · FY2021 · DK

Training Innate Immunity: A new approach to the treatment of Sepsis

$553,544
David L. Williams · East Tennessee State University · R01 · FY2021 · GM

Project 2: Leveraging Metagenomics of the Microbiome to predict colonization/infection by antimicrobial-resistant pathogens

$553,418
Samuel A Shelburne · University Of Texas Hlth Sci Ctr Houston · P01 · FY2020 · AI

Development of Paratransgenic Ticks for Disease Control

$553,378
Ulrike Gertrud Munderloh · University Of Minnesota · R01 · FY2020 · AI

Development of Paratransgenic Ticks for Disease Control

$553,352
Ulrike Gertrud Munderloh · University Of Minnesota · R01 · FY2022 · AI

Development of Paratransgenic Ticks for Disease Control

$553,352
Ulrike Gertrud Munderloh · University Of Minnesota · R01 · FY2019 · AI